Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Open-Label Study Evaluating the Safety, Tolerability, and Efficacy of Pridopidine in Patients With Huntington's Disease (Open PRIDE-HD)

NCT02494778 is registered in ClinicalTrials.gov with Prilenia as lead sponsor.

NCT NCT02494778
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02494778 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Open-Label Study Evaluating the Safety, Tolerability, and Efficacy of Pridopidine in Patients With Huntington's Disease (Open PRIDE-HD)
Lead sponsor
Prilenia
Phase
Phase 2
Overall status
Terminated
Start date
September 24, 2015
Completion date
January 12, 2018
Enrollment
248 (actual)
Sites
46

Conditions

As the registry lists them; a condition with its own page is linked.

huntington's disease